Why people use Semaglutide for weight loss
Ozempic / Wegovy for weight. How does it work, what should you expect? The honest answer: yes, and it clears the highest bar - it is FDA-approved for this. STEP-1 trial: 14.9% average body weight loss at 68 weeks.
This page covers what's known, what's not, and what the editorial take is for normal humans considering Semaglutide for weight loss.
What the evidence says
Evidence tier: FDA-approved. FDA-approved with multiple randomized trials behind it. The strongest evidence tier in this matrix.
- STEP-1 trial: 14.9% average body weight loss at 68 weeks.
- FDA-approved as Wegovy for obesity (BMI 30+, or 27+ with comorbidity).
- Most-prescribed GLP-1 globally; longest real-world track record.
Protocol notes
Once-weekly subcutaneous injection. Titration: 0.25mg -> 0.5mg -> 1mg -> 1.7mg -> 2.4mg over 16+ weeks.
Always with a sports-medicine doctor, telehealth provider, or specialist sign-off. Self-experimenting on injection schedules without clinical input is the most common way people waste money and get hurt.
What to skip
- Vendors without a Certificate of Analysis (COA). Random gym-bro vendors with no third-party testing. The peptide market has a quality-control problem; the answer is COA per peptide, every time.
- Pre-mixed blends from non-pharmacy sources. Compounding pharmacies that produce pre-mixed combinations with COAs are fine. Random vendor "stack vials" are not.
- Massively over-dosed protocols. More is rarely better with peptides. Receptor saturation is real. Stick to evidence-based dosing.
Where to go next
- Full Semaglutide directory entry - status, sourcing, studies, what to skip
- What are peptides - if you skipped the foundation
- How peptides actually work - mechanism in plain English
- The Tier List - which ones to take seriously
- Subscribe to the dispatch